Q1 2021 13F Holders as of 31 Mar 2021
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
7,081,865
-
Share change
-
-596,425
-
Total reported value
-
$8,496,337
-
Put/Call ratio
-
48%
-
Price per share
-
$1.20
-
Number of holders
-
29
-
Value change
-
-$3,198,218
-
Number of buys
-
16
-
Number of sells
-
18
Institutional Holders of MILLENDO THERAPEUTICS INC - COM (MLND) as of Q1 2021
As of 31 Mar 2021,
MILLENDO THERAPEUTICS INC - COM (MLND) was held by
29 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
7,081,865 shares.
The largest 10 holders included
NEA Management Company, LLC, Ikarian Capital, LLC, RENAISSANCE TECHNOLOGIES LLC, Monashee Investment Management LLC, CITADEL ADVISORS LLC, VANGUARD GROUP INC, ACADIAN ASSET MANAGEMENT LLC, TWO SIGMA ADVISERS, LP, BRIDGEWAY CAPITAL MANAGEMENT, LLC, and BOOTHBAY FUND MANAGEMENT, LLC.
This page lists
29
institutional shareholders reporting positions in this security
for the Q1 2021 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.